Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other 3

Conditions

Opioid-Induced Constipation 8Neoplasms 3Constipation 2Urinary Bladder Neoplasms 1Pain 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × naloxegol × Clear all
NCT04294550 2022-02-28

Study on Quality of Life in Advanced Cancer Patients With Opioid-induced Constipation Treated With Naloxegol

Fondazione ANT Italia ONLUS

Completed
250 enrolled
Other

Opioid-Induced Constipation, Neoplasms

NCT02745353 2019-12-09

Naloxegol in Cancer Opioid-Induced Constipation

University of California, San Diego

Phase 2 Terminated
7 enrolled 9 charts
Other

Constipation, Neoplasms

NCT02839889 2019-03-05

Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)

Hospice of Henderson County, Inc.

Phase 4 Terminated
12 enrolled 33 charts
Other

Constipation, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡